Stock listing

Terns Pharmaceuticals, Inc.

Selected listing: 430 · MUN · EUR · DE

Terns Pharmaceuticals, Inc. (Munich:430). Latest release Sep 10, 2026: TERN Awarded $11.26 Million U.S. Army Contract to Deploy Next Generation Positioning…

430:MUNEURDEUpdated October 3, 2026
Terns Pharmaceuticals, Inc. logo
Ticker
Munich:430
Asset type
Stock
Exchange
Munich
Currency
EUR

About Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. (Ticker: TERN) is a public company based in the United States focused on developing innovative therapies for liver diseases. The company is dedicated to advancing its pipeline of drug candidates aimed at addressing unmet medical needs in this area. Terns Pharmaceuticals is committed to improving patient outcomes through its research and development efforts.

Latest news from Terns Pharmaceuticals, Inc.

All Terns Pharmaceuticals, Inc. news →

Research Terns Pharmaceuticals, Inc.

Alternate listings